Operating Lease, Right-of-Use Asset of PACIFIC BIOSCIENCES OF CALIFORNIA, INC. from 01 Jan 2019 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 01 Jan 2019 to 31 Dec 2025.
  • PACIFIC BIOSCIENCES OF CALIFORNIA, INC. Operating Lease, Right-of-Use Asset for the quarter ending 31 Dec 2025 was $41,695,000, a 159% increase year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

PACIFIC BIOSCIENCES OF CALIFORNIA, INC. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $41,695,000 +$25,604,000 +159% 31 Dec 2025 10-K 25 Feb 2026 2025 FY
Q3 2025 $42,583,000 +$25,239,000 +146% 30 Sep 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 $43,504,000 +$21,113,000 +94% 30 Jun 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 $44,408,000 +$13,736,000 +45% 31 Mar 2025 10-Q 12 May 2025 2025 Q1
Q4 2024 $16,091,000 -$16,502,000 -51% 31 Dec 2024 10-K 25 Feb 2026 2025 FY
Q3 2024 $17,344,000 -$17,266,000 -50% 30 Sep 2024 10-Q 12 Nov 2024 2024 Q3
Q2 2024 $22,391,000 -$14,053,000 -39% 30 Jun 2024 10-Q 09 Aug 2024 2024 Q2
Q1 2024 $30,672,000 -$7,575,000 -20% 31 Mar 2024 10-Q 09 May 2024 2024 Q1
Q4 2023 $32,593,000 -$7,170,000 -18% 31 Dec 2023 10-K 17 Mar 2025 2024 FY
Q3 2023 $34,610,000 -$6,923,000 -17% 30 Sep 2023 10-Q 03 Nov 2023 2023 Q3
Q2 2023 $36,444,000 -$6,830,000 -16% 30 Jun 2023 10-Q 04 Aug 2023 2023 Q2
Q1 2023 $38,247,000 -$6,674,000 -15% 31 Mar 2023 10-Q 04 May 2023 2023 Q1
Q4 2022 $39,763,000 -$6,854,000 -15% 31 Dec 2022 10-K 28 Feb 2024 2023 FY
Q3 2022 $41,533,000 -$4,329,000 -9.4% 30 Sep 2022 10-Q 08 Nov 2022 2022 Q3
Q2 2022 $43,274,000 +$14,694,000 +51% 30 Jun 2022 10-Q 08 Aug 2022 2022 Q2
Q1 2022 $44,921,000 +$15,759,000 +54% 31 Mar 2022 10-Q 06 May 2022 2022 Q1
Q4 2021 $46,617,000 +$16,666,000 +56% 31 Dec 2021 10-K 28 Feb 2023 2022 FY
Q3 2021 $45,862,000 +$15,162,000 +49% 30 Sep 2021 10-Q 05 Nov 2021 2021 Q3
Q2 2021 $28,580,000 -$2,855,000 -9.1% 30 Jun 2021 10-Q 06 Aug 2021 2021 Q2
Q1 2021 $29,162,000 -$2,956,000 -9.2% 31 Mar 2021 10-Q 06 May 2021 2021 Q1
Q4 2020 $29,951,000 -$2,876,000 -8.8% 31 Dec 2020 10-K 28 Feb 2022 2021 FY
Q3 2020 $30,700,000 -$2,810,000 -8.4% 30 Sep 2020 10-Q 03 Nov 2020 2020 Q3
Q2 2020 $31,435,000 -$2,740,000 -8% 30 Jun 2020 10-Q 06 Aug 2020 2020 Q2
Q1 2020 $32,118,000 -$2,693,000 -7.7% 31 Mar 2020 10-Q 08 May 2020 2020 Q1
Q4 2019 $32,827,000 -$2,673,000 -7.5% 31 Dec 2019 10-K 26 Feb 2021 2020 FY
Q3 2019 $33,510,000 30 Sep 2019 10-Q 07 Nov 2019 2019 Q3
Q2 2019 $34,175,000 30 Jun 2019 10-Q 06 Aug 2019 2019 Q2
Q1 2019 $34,811,000 31 Mar 2019 10-Q 03 May 2019 2019 Q1
Q4 2018 $35,500,000 01 Jan 2019 10-K 28 Feb 2020 2019 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.